Objectives: To study the natural course of viremia during primary HIV infec
tion (PHI).
Method: Eight patients were followed from a median of 5 days from the onset
of PHI illness. Plasma HIV-1 RNA levels were measured frequently and the r
esults were fitted to mathematical models. HIV-1 RNA levels were also monit
ored in nine patients given two reverse transcriptase inhibitors and a prot
ease inhibitor after a median of 7 days from the onset of Pi-II illness.
Results: HIV-1 RNA appeared in the blood during the week preceding onset of
PHI illness and increased rapidly during the first viremic phase, reaching
a peak at a mean of 7 days after onset of illness. This was followed by a
phase of rapidly decreasing levels of HIV-1 RNA to an average of 21 days af
ter onset. Viral density continued to decline thereafter but at a 5- to 50-
fold lower rate; a steady-state level was reached at a median of 2 months a
fter onset of PHI. Peak viral density levels correlated significantly with
levels measured between days 50 and 600. Initiation of antiretroviral treat
ment during PHI resulted in rapidly declining levels to below 50 copies/ml.
Conclusions: This study demonstrates the kinetic phases of viremia during P
HI and indicates two new contributions to the natural history of HIV-1 infe
ction: PHI peak levels correlate with steady-state levels and HIV-1 RNA dec
lines biphasically; an initial rapid decay is usually followed by a slow de
cay, which is similar to the initial changes seen with antiviral treatment.
(C) 2000 Lippincott Williams & Wilkins.